Whan In Pharm Co.,Ltd. (016580.KS) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	273.5B	255.2B	259.6B	230.4B	198.9B
Cost of Revenue	148.3B	148.6B	165.8B	132.3B	100.1B
Gross Profit	125.2B	106.7B	93.8B	98.1B	98.8B
Operating Expenses
R&D Expense	4.8B	22.0B	771.1M	1.1B	3.3B
SG&A Expense	45.9B	33.7B	38.7B	36.4B	35.3B
General & Admin Expense	16.1B	19.8B	18.2B	18.7B	17.6B
Selling & Marketing Expense	16.3B	13.9B	20.5B	17.7B	17.7B
Other Expenses	52.4B	37.9B	32.8B	31.5B	30.4B
Total Operating Expenses	102.9B	93.6B	72.3B	66.4B	69.0B
Cost and Expenses	251.2B	242.2B	238.1B	197.9B	169.1B
Operating Income (EBIT)	22.3B	13.0B	21.5B	32.5B	29.8B
Non-Operating
Interest Income	1.6B	1.5B	2.4B	3.3B	2.2B
Interest Expense	34.6M	28.8M	23.1M	22.7M	51.9M
Net Interest Income	1.6B	1.5B	2.3B	3.3B	2.1B
Other Non-Op Income/Expense	3.2B	1.9B	5.5B	1.3B	(2.3M)
Non-Operating Income (excl Interest)	(768.3M)	(1.9B)	(3.5B)	(1.3B)	(250.7M)
EBT (Pre-Tax Income)	25.5B	14.9B	26.9B	33.8B	29.8B
Income Tax Expense	5.1B	1.3B	3.6B	4.0B	6.1B
Bottom Line
Net Income	20.5B	13.6B	23.4B	29.8B	23.9B
Earnings from Cont. Ops	20.5B	13.6B	23.4B	29.8B	23.7B
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	20.5B	13.6B	23.4B	29.8B	23.9B
Per Share
Basic EPS	₩1,131	₩857	₩1,532	₩1,950	₩1,567
Diluted EPS	₩1,131	₩857	₩1,531	₩1,950	₩1,567
Revenue Per Share	₩14,703	₩13,721	₩17,004	₩15,091	₩13,030
Shares
Basic Shares Outstanding	18.6M	18.6M	15.3M	15.3M	15.3M
Diluted Shares Outstanding	18.6M	18.6M	15.3M	15.3M	15.3M
Profitability Metrics
EBITDA	29.7B	24.1B	33.4B	40.5B	34.7B
D&A	9.4B	11.0B	8.5B	6.7B	4.6B
EBIT	22.8B	13.0B	25.0B	33.8B	30.1B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026